This website uses cookies to ensure you get the best experience on our website.
- Table of Contents
, No Gclids
Disease Info Card
Idiopathic Pulmonary Hypertension
Information about Idiopathic Pulmonary Hypertension: characteristics, related genes and pathways, plus antibodies you can use for research. This page is being enriched constantly, if you see some information you would like this page to include please send your suggestions to us.
Overview of Idiopathic Pulmonary Hypertension
Most recent studies have shown that Idiopathic Pulmonary Hypertension shares some biological mechanisms with congenital-heart-disease, connective-tissue-diseases, diffuse-scleroderma, dyspnea, fibrosis, heart-diseases, heart-failure, hypertensive-disease, hypertrophy, hypoxia, lung-diseases, pathologic-vasoconstriction, pulmonary-embolism, pulmonary-fibrosis, pulmonary-hypertension, right-ventricular-failure, right-ventricular-hypertrophy, sclerosis, vascular-diseases.
Among the many pathways, these few ones have gauged particular interests from scientists studying Idiopathic Pulmonary Hypertension, and have been seen in publications frequently: Angiogenesis, Cell Cycle, Cell Growth, Cell Proliferation, Coagulation, Endothelial Cell Proliferation, Inflammatory Response, Localization, Muscle Cell Proliferation, Pathogenesis, Platelet Activation, Platelet Aggregation, Response To Hypoxia, Secretion, Smooth Muscle Cell Proliferation, Transport, Transposition, Vasoconstriction, Vasodilation, Virulence
Quite a number of genes have been found to play important roles in Idiopathic Pulmonary Hypertension, such as ASAP1, ASAP2, BLOC1S6, BMPR2, EDN1, ENO1, MCAT, MCPH1, MRPS30, PAH, PAPOLA, PDAP1, PVR, REG3A, SLC16A1, TUSC2. See what Boster has to offer for the research of these genes by clicking the gene name links below and view a more detailed info card/product listing for that gene.
In a later update, we will include information such as current drugs and therapy solutions as well as on-going and past clinical trials for this disease. Plesae stay updated.